Thura, M., Al-Aidaroos, A. Q., Gupta, A., Chee, C. E., Lee, S. C., Hui, K. M., . . . Zeng, Q. (2019). PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein. Nature Portfolio.
Style de citation Chicago (17e éd.)Thura, Min, et al. PRL3-zumab as an Immunotherapy to Inhibit Tumors Expressing PRL3 Oncoprotein. Nature Portfolio, 2019.
Style de citation MLA (8e éd.)Thura, Min, et al. PRL3-zumab as an Immunotherapy to Inhibit Tumors Expressing PRL3 Oncoprotein. Nature Portfolio, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.